Company Description (as filed with the SEC)
Flamel Technologies is a specialty pharmaceutical company with a long history of expertise in drug delivery, focusing on the development of safer and more efficacious formulations, tackling unmet medical needs in the process. We are focusing on (1) the development and licensing of five versatile, proprietary drug delivery platforms (2) the development of novel, high-value products based on our drug delivery platforms and (3) as a result of our acquisition of Éclat Pharmaceuticals, LLC, or Éclat, the development, approval, and commercialization of niche branded and generic pharmaceutical products in the U.S. The Company’s versatile, proprietary drug delivery platforms are appropriate for more effectively and safely administering medicines to patients. ... More ...